Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Pathogenesis of accelerated fibrosis in HIV/HCV co-infection.

Lin W, Weinberg EM, Chung RT.

J Infect Dis. 2013 Mar;207 Suppl 1:S13-8. doi: 10.1093/infdis/jis926. Review.

2.

HIV and hepatitis C coinfection: pathogenesis and microbial translocation.

Page EE, Nelson M, Kelleher P.

Curr Opin HIV AIDS. 2011 Nov;6(6):472-7. doi: 10.1097/COH.0b013e32834bbc71. Review.

PMID:
21918438
3.

HIV and hepatitis C virus: special concerns for patients with cirrhosis.

Curry MP.

J Infect Dis. 2013 Mar;207 Suppl 1:S40-4. doi: 10.1093/infdis/jis763. Review.

4.

Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.

Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V.

Int J Mol Sci. 2014 May 26;15(6):9184-208. doi: 10.3390/ijms15069184. Review.

5.

Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.

Bierhoff E, Fischer HP, Willsch E, Rockstroh J, Spengler U, Brackmann HH, Oldenburg J.

Virchows Arch. 1997 Apr;430(4):271-7.

PMID:
9134037
6.

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients.

Sagnelli C, Uberti-Foppa C, Galli L, Pasquale G, Coppola N, Albarello L, Doglioni C, Lazzarin A, Sagnelli E.

Braz J Infect Dis. 2014 Mar-Apr;18(2):164-9. doi: 10.1016/j.bjid.2013.06.005. Epub 2013 Oct 25.

7.

HCV and HIV co-infection: mechanisms and management.

Chen JY, Feeney ER, Chung RT.

Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):362-71. doi: 10.1038/nrgastro.2014.17. Epub 2014 Feb 18. Review.

8.

HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.

Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J; ANRS CO13 HEPAVIH Study Group.

PLoS One. 2012;7(11):e50289. doi: 10.1371/journal.pone.0050289. Epub 2012 Nov 30.

9.

HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.

Lin W, Wu G, Li S, Weinberg EM, Kumthip K, Peng LF, Méndez-Navarro J, Chen WC, Jilg N, Zhao H, Goto K, Zhang L, Brockman MA, Schuppan D, Chung RT.

J Biol Chem. 2011 Jan 28;286(4):2665-74. doi: 10.1074/jbc.M110.168286. Epub 2010 Nov 22.

10.

Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.

Berzsenyi MD, Woollard DJ, McLean CA, Preiss S, Perreau VM, Beard MR, Scott Bowden D, Cowie BC, Li S, Mijch AM, Roberts SK.

J Hepatol. 2011 Sep;55(3):536-44. doi: 10.1016/j.jhep.2010.12.021. Epub 2011 Jan 23.

PMID:
21266183
11.

Natural history of liver disease and effect of hepatitis C virus on HIV disease progression.

Ingiliz P, Rockstroh JK.

Curr Opin HIV AIDS. 2015 Sep;10(5):303-8. doi: 10.1097/COH.0000000000000187. Review.

PMID:
26248118
12.

Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.

Glässner A, Eisenhardt M, Kokordelis P, Krämer B, Wolter F, Nischalke HD, Boesecke C, Sauerbruch T, Rockstroh JK, Spengler U, Nattermann J.

J Hepatol. 2013 Sep;59(3):427-33. doi: 10.1016/j.jhep.2013.04.029. Epub 2013 May 9.

PMID:
23665286
13.

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.

Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y, Matthews GV, Lange JM, Ruxrungtham K; HIV-NAT125 study team.

J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.

PMID:
24730732
14.

[Hepatitis and posthepatic cirrhosis in AIDS].

Bierhoff E, Fischer HP, Pfeifer U, Rockstroh J, Spengler U.

Verh Dtsch Ges Pathol. 1995;79:249-53. German.

PMID:
8600688
15.

HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects.

Hu S, Ghabril M, Amet T, Hu N, Byrd D, Yang K, Vuppalanchi R, Saxena R, Desai M, Lan J, Johnson R, Gupta S, Chalasani N, Yu Q.

PLoS One. 2014 Feb 6;9(2):e86964. doi: 10.1371/journal.pone.0086964. eCollection 2014.

16.

Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.

Pace FH, Ferreira LE, Silva AE, Ferraz ML.

Rev Soc Bras Med Trop. 2012 Jul-Aug;45(4):444-7.

17.

Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.

Anggorowati N, Yano Y, Heriyanto DS, Rinonce HT, Utsumi T, Mulya DP, Subronto YW, Hayashi Y.

J Med Virol. 2012 Jun;84(6):857-65. doi: 10.1002/jmv.23293.

PMID:
22499006
18.

Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus.

Ansari AW, Schmidt RE, Shankar EM, Kamarulzaman A.

J Transl Med. 2014 Dec 10;12:341. doi: 10.1186/s12967-014-0341-8. Review.

19.

Comparison of liver fibrosis progression in HIV/HCV co-infected and HCV mono-infected patients by transient elastometry.

Mazzocato S, Orsetti E, Gesuita R, Piraccini F, Drenaggi D, Barchiesi F.

Scand J Infect Dis. 2014 Nov;46(11):797-802. doi: 10.3109/00365548.2014.952245. Epub 2014 Sep 22.

PMID:
25244675
20.

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.

Merchante N, Macías J, Ramayo E, Vergara S, García-García JA, Mira JA, Corzo JE, Gómez-Mateos JM, Lozano F, Pineda JA.

J Viral Hepat. 2006 Jul;13(7):449-56.

PMID:
16792538
Items per page

Supplemental Content

Write to the Help Desk